These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 1587057)

  • 21. Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.
    Bourgoin H; Paintaud G; Büchler M; Lebranchu Y; Autret-Leca E; Mentré F; Le Guellec C
    Br J Clin Pharmacol; 2005 Jan; 59(1):18-27. PubMed ID: 15606436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics. Theory and clinical application.
    Whiting B; Kelman AW; Grevel J
    Clin Pharmacokinet; 1986; 11(5):387-401. PubMed ID: 3536257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
    Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
    Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Principles of therapeutic drug monitoring.
    Zhao W; Jacqz-Aigrain E
    Handb Exp Pharmacol; 2011; 205():77-90. PubMed ID: 21882106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models.
    Rosner GL; Müller P
    J Pharmacokinet Biopharm; 1997 Apr; 25(2):209-33. PubMed ID: 9408860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic drug monitoring in neonates.
    Pauwels S; Allegaert K
    Arch Dis Child; 2016 Apr; 101(4):377-81. PubMed ID: 26803050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic drug monitoring in a paediatric epilepsy clinic.
    Botha J; Bobat RA; Moosa A; Miller R
    S Afr Med J; 1990 May; 77(10):511-4. PubMed ID: 2343349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian population approaches to the analysis of dose escalation studies.
    Russu A; De Nicolao G; Poggesi I; Neve M; Gomeni R
    Comput Methods Programs Biomed; 2012 Aug; 107(2):189-201. PubMed ID: 21764475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic drug monitoring of cancer chemotherapy.
    Alnaim L
    J Oncol Pharm Pract; 2007 Dec; 13(4):207-21. PubMed ID: 18045780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics.
    Paci A; Veal G; Bardin C; Levêque D; Widmer N; Beijnen J; Astier A; Chatelut E
    Eur J Cancer; 2014 Aug; 50(12):2010-9. PubMed ID: 24889915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A program for the optimum design of pharmacokinetic, pharmacodynamic, drug metabolism and drug-drug interaction models.
    Graham G; Gueorguieva I; Dickens K
    Comput Methods Programs Biomed; 2005 Jun; 78(3):237-49. PubMed ID: 15899308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian optimal designs for pharmacokinetic models: sensitivity to uncertainty.
    Dokoumetzidis A; Aarons L
    J Biopharm Stat; 2007; 17(5):851-67. PubMed ID: 17885870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of new software (Ver. 2.0) based on the Bayesian estimation utilized in the therapeutic drug monitoring of teicoplanin, a glycopeptide antibiotic].
    Niwa T; Tabata K; Kimura J; Kamada M; Noda Y; Takagi A
    Jpn J Antibiot; 2006 Jun; 59(3):165-76. PubMed ID: 16913403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian forecasting in paediatric populations.
    Fernández de Gatta MM; García MJ; Lanao JM; Domínguez-Gil A
    Clin Pharmacokinet; 1996 Nov; 31(5):325-30. PubMed ID: 9118582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cost-effectiveness analysis of active TDM in elderly patients treated with aminoglycosides].
    Leon-Djian CB; Bourguignon L; Späth HM; Maire P
    Therapie; 2011; 66(5):445-52. PubMed ID: 22031689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Personalised dosing of medicines for children.
    Al-Metwali B; Mulla H
    J Pharm Pharmacol; 2017 May; 69(5):514-524. PubMed ID: 28266713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
    Proost JH; Schiere S; Eleveld DJ; Wierda JM
    Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic drug monitoring in pregnancy.
    Matsui DM
    Ther Drug Monit; 2012 Oct; 34(5):507-11. PubMed ID: 22846897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring.
    Brocks DR; Hamdy DA
    Res Pharm Sci; 2020 Dec; 15(6):503-514. PubMed ID: 33828594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.